NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
Press Release
Read More
Randomized Controlled Trials (RCTs) and Real-world Outcomes in Hematological Malignancies: Minding the Gap
Blog
Read More
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
Press Release
Read More
ConcertAI & NeoGenomics Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at 2024 JP Morgan Conference
Press Release
Read More
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Press Release
Read More